Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Freywald

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Cellular & Molecular Immunology|September 9, 2014
Transgenic 4-1BBL-engineered vaccine stimulates potent Gag-specific therapeutic and long-term immunity via increased priming of CD44(+)CD62L(high) IL-7R(+) CTLs with up- and downregulation of anti- and pro-apoptosis genesRong Wang, Andrew Freywald, Yue Chen, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 31, 2022
A CRISPR Platform for Targeted In Vivo ScreensVincent Maranda, Yue Zhang, Frederick S Vizeacoumar, et al.
Cellular & Molecular Immunology|October 9, 2012
A novel T cell-based vaccine capable of stimulating long-term functional CTL memory against B16 melanoma via CD40L signalingYufeng Xie, Lu Wang, Andrew Freywald, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2006
EphA receptors inhibit anti-CD3-induced apoptosis in thymocytesAndrew Freywald, Nigel Sharfe, Charlotte D'E Miller, et al.
Trends in Molecular Medicine|December 3, 2014
Building high-resolution synthetic lethal networks: a 'Google map' of the cancer cellJames M Paul, Shaina D Templeton, Akanksha Baharani, et al.
Trends in Cancer|January 9, 2019
A Road Map to Personalizing Targeted Cancer Therapies Using Synthetic LethalitySreejit Parameswaran, Deeksha Kundapur, Frederick S Vizeacoumar, et al.
Immunology|November 2, 2012
Differential requirements of CD4(+) T-cell signals for effector cytotoxic T-lymphocyte (CTL) priming and functional memory CTL development at higher CD8(+) T-cell precursor frequencyChannakeshava S Umeshappa, Roopa H Nanjundappa, Yufeng Xie, et al.
Cellular & Molecular Immunology|June 7, 2016
Novel exosome-targeted T-cell-based vaccine counteracts T-cell anergy and converts CTL exhaustion in chronic infection via CD40L signaling through the mTORC1 pathwayRong Wang, Aizhang Xu, Xueying Zhang, et al.
Cancers|January 12, 2021
Protein Tyrosine Kinases: Their Roles and Their Targeting in LeukemiaKalpana K Bhanumathy, Amrutha Balagopal, Frederick S Vizeacoumar, et al.
Molecular Immunology|November 6, 2007
EphA and ephrin-A proteins regulate integrin-mediated T lymphocyte interactionsNigel Sharfe, Martina Nikolic, Lorand Cimpeon, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Cellular & Molecular Immunology|September 9, 2014
Transgenic 4-1BBL-engineered vaccine stimulates potent Gag-specific therapeutic and long-term immunity via increased priming of CD44(+)CD62L(high) IL-7R(+) CTLs with up- and downregulation of anti- and pro-apoptosis genesRong Wang, Andrew Freywald, Yue Chen, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 31, 2022
A CRISPR Platform for Targeted In Vivo ScreensVincent Maranda, Yue Zhang, Frederick S Vizeacoumar, et al.
Cellular & Molecular Immunology|October 9, 2012
A novel T cell-based vaccine capable of stimulating long-term functional CTL memory against B16 melanoma via CD40L signalingYufeng Xie, Lu Wang, Andrew Freywald, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2006
EphA receptors inhibit anti-CD3-induced apoptosis in thymocytesAndrew Freywald, Nigel Sharfe, Charlotte D'E Miller, et al.
Trends in Molecular Medicine|December 3, 2014
Building high-resolution synthetic lethal networks: a 'Google map' of the cancer cellJames M Paul, Shaina D Templeton, Akanksha Baharani, et al.
Trends in Cancer|January 9, 2019
A Road Map to Personalizing Targeted Cancer Therapies Using Synthetic LethalitySreejit Parameswaran, Deeksha Kundapur, Frederick S Vizeacoumar, et al.
Immunology|November 2, 2012
Differential requirements of CD4(+) T-cell signals for effector cytotoxic T-lymphocyte (CTL) priming and functional memory CTL development at higher CD8(+) T-cell precursor frequencyChannakeshava S Umeshappa, Roopa H Nanjundappa, Yufeng Xie, et al.
Cellular & Molecular Immunology|June 7, 2016
Novel exosome-targeted T-cell-based vaccine counteracts T-cell anergy and converts CTL exhaustion in chronic infection via CD40L signaling through the mTORC1 pathwayRong Wang, Aizhang Xu, Xueying Zhang, et al.
Cancers|January 12, 2021
Protein Tyrosine Kinases: Their Roles and Their Targeting in LeukemiaKalpana K Bhanumathy, Amrutha Balagopal, Frederick S Vizeacoumar, et al.
Molecular Immunology|November 6, 2007
EphA and ephrin-A proteins regulate integrin-mediated T lymphocyte interactionsNigel Sharfe, Martina Nikolic, Lorand Cimpeon, et al.
Pageof 7